Kardigan, Inc. (KARD) Stock Ticker
KARD right now
Market factors today
Unlock the full KARD picture
About Kardigan, Inc.
Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.
KARD stock facts
| Ticker symbol | KARD |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $1.3B |
| CEO | Tassos Gianakakos |
| Employees | 241 |
| Headquarters | Princeton, NJ, US |
| IPO date | 2026-06-18 |
| Website | www.kardigan.bio |
What you can see for KARD on Tickr
Live KARD price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the KARD report.
Rankings
FAQ
What is the ticker symbol for Kardigan, Inc.?
The ticker symbol for Kardigan, Inc. is KARD, listed on the NASDAQ.
What is KARD?
Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve…